Detalles de la búsqueda
1.
Effectiveness of BNT162b2 BA.4/5 Bivalent mRNA Vaccine Against Symptomatic COVID-19 Among Immunocompetent Individuals Testing at a Large US Retail Pharmacy.
J Infect Dis
; 229(3): 648-659, 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37925630
2.
A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves.
BMC Infect Dis
; 23(1): 117, 2023 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36829137
3.
Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021).
BMC Infect Dis
; 23(1): 490, 2023 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37488478
4.
Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012-2019.
Crit Care Med
; 50(3): 460-468, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34534129
5.
The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012-2019.
BMC Infect Dis
; 22(1): 775, 2022 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36199012
6.
Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation.
BMC Infect Dis
; 22(1): 841, 2022 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368931
7.
Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa.
Clin Infect Dis
; 71(2): 304-310, 2020 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31545346
8.
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019.
Infect Control Hosp Epidemiol
; 43(3): 277-283, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35322770
9.
Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014-2019.
Crit Care Explor
; 4(4): e0667, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35415613
10.
Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019.
PLoS One
; 17(12): e0276192, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36490261
11.
The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant Pseudomonas aeruginosa Infections.
Antibiotics (Basel)
; 11(5)2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35625270
12.
Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa.
Microbiol Spectr
; 10(5): e0233622, 2022 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36005836
13.
Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia.
Antibiotics (Basel)
; 11(8)2022 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36009902
14.
Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
JAMA Netw Open
; 5(12): e2246915, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36515946
15.
A Multicenter Comparison of Prevalence and Predictors of Antimicrobial Resistance in Hospitalized Patients Before and During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.
Open Forum Infect Dis
; 9(11): ofac537, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36381612
16.
A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections.
Open Forum Infect Dis
; 8(3): ofab089, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33796600
17.
Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020.
JAMA Netw Open
; 4(4): e216556, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33830226
18.
Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti-pseudomonal ß-lactam: Does "S" equal success in the presence of resistance to other anti-pseudomonal ß-lactams?
Pharmacotherapy
; 41(8): 658-667, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34097763
19.
Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting.
Infect Dis Ther
; 9(1): 107-117, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31974828
20.
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial.
Infect Dis Ther
; 9(4): 953-966, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32996064